tiprankstipranks

Mark T Iwicki Insider Profile

18 Followers
Mark T Iwicki, Director at Aimmune Therapeutics, holds 286.31K shares in Kala Pharmaceuticals (Ticker: KALA), holds 73.58K shares in Merus (Ticker: MRUS), holds 0.00 shares in Aimmune Therapeutics (Ticker: AIMT).
tipranks
Mark T Iwicki

Mark T Iwicki
Aimmune Therapeutics (AIMT)
Director

Ranked #37,135 out of 98,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+26.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
57.71%
32.54%
9.76%
0.00%
0.00% Others
A breakdown of Mark T Iwicki's holdings

Insider Roles

Merus
(MRUS)
Director
Kala Pharmaceuticals
(KALA)
CEO, Director
Pulmatrix
(PULM)
Director
Akero Therapeutics
(AKRO)
Director
+3 other positions
Roles that Mark T Iwicki holds in companies

Most Profitable Insider Trade

Stock:
Merus
(MRUS)
Rating:Informative Buy
Date:Apr 17, 2023 - Apr 17, 2024
Return:+71.40%
The most profitable trade made by Mark T Iwicki

Mark T Iwicki's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AIMT
Aimmune Therapeutics
Oct 14, 2020
Uninformative Sell
270.48K
$0.00
Kala Pharmaceuticals
Jan 05, 2024
CEO, Director
Uninformative Buy
$2.01M
Pulmatrix
Apr 05, 2018
Director
Uninformative Buy
$601.72K
Akero Therapeutics
Director
Merus
Apr 17, 2023
Director
Informative Buy
534.68K
$3.56M
Aerovate Therapeutics
Director
Third Harmonic Bio, Inc.
Director
Q32 Bio
Director
List of latest transactions for each holding click on a transaction to see Mark T Iwicki's performance on stock

Mark T Iwicki insider profile FAQ

What is the percentage of profitable transactions made by Mark T Iwicki?
The percentage of profitable transactions made by Mark T Iwicki is 50%.
    What is the average return per transaction made by Mark T Iwicki?
    The average return per transaction made by Mark T Iwicki is 26.60%.
      What stocks does Mark T Iwicki hold?
      Mark T Iwicki holds: AIMT, KALA, PULM, AKRO, MRUS, AVTE, THRD, QTTB stocks.
        What was Mark T Iwicki’s latest transaction?
        Mark T Iwicki latest transaction was an Uninformative Buy of ―.
          What was Mark T Iwicki's most profitable transaction?
          Mark T Iwicki’s most profitable transaction was an Informative Buy of MRUS stock on April 17, 2023. The return on the trade was 71.40%.
            What is Mark T Iwicki's role in Aimmune Therapeutics?
            Mark T Iwicki's role in Aimmune Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.